Pure akinesia: An unusual phenotype of Hallervorden-Spatz syndrome

Movement Disorders

Volumn 18, Issue 11, 2003, Pages 1351-1353

  Molinuevo, José L ^a   Martí, María J ^a   Blesa, Rafael ^a   Tolosa, Eduardo ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Hallervorden Spatz; Magnetic resonance imaging; PANK2 gene; Parkinsonian; Progressive supranuclear palsy; Pure akinesia

Indexed keywords

ALANINE; BACLOFEN; BOTULINUM TOXIN; CLONAZEPAM; CYSTEINE; DNA; DOPAMINE RECEPTOR STIMULATING AGENT; GLYCINE; LEVODOPA; PANTOTHENATE KINASE; THREONINE;

ADULT; AGED; AKINESIA; ANAMNESIS; ARTICLE; BIOCHEMISTRY; CASE REPORT; CLINICAL FEATURE; CRANIAL NERVE; FEMALE; GAIT DISORDER; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC SCREENING; HALLERVORDEN SPATZ DISEASE; HETEROZYGOSITY; HUMAN; MALE; MISSENSE MUTATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIBLING; STUTTERING; TREATMENT FAILURE;

ADULT; AGED; BRAIN; FEMALE; HALLERVORDEN-SPATZ SYNDROME; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUTATION, MISSENSE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POINT MUTATION;

EID: 1342305000     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10520     Document Type: Article

References (13)

1. Hallervorden J, Spatz H. Eigenartige Erkrankung im extrapyramidalem system mit besonderer beteiligung des globus pallidus und der substantia nigra. Z Gesamte Neurol Psychiatr 1922;79:254-302.
2. Dooling EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol 1974;30:70-83.
3. Jankovic J, Kirkpatrick, JB, Blomquist KA, Langlais PJ, Bird DE. Late onset Hallervorden-Spatz disease presenting as a familial parkinsonism. Neurology 1985;35:227-234.
4. Grimes DA, Lang AE, Bergeron C. Late adult onset chorea with typical pathology of Hallervorden Spatz syndrome. J Neurol Neurosurg Psychiatry 2000;69:392-395.
5. Swaiman KF. Hallervorden Spatz syndrome and brain iron metabolism. Arch Neurol 1991;48:1285-1293.
6. Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001;28:345-349.
7. Narabayashi H, Imai H, Yokochi M, Hirayama K, Nakamura R. Cases of pure akinesia without rigidity and tremor and with no effect by L-dopa therapy. In: Birkmayer W, Homykiewicz O, editors. Advances in parkinsonism. Basel: Roche; 1976. p 335-342.
8. Pramstaller PP, Salerno A, Bathia KP, Prugger M, Marsden CD. Primary central nervous system lymphoma presenting with a parkinsonian syndrome of pure akinesia. J Neurol 1999;246:934-938.
9. Sethi KD, Adams RJ, Loring DW, El Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692-694.
10. Nasreddine ZS, Loginov M, Clark LN, Lamarche J, Miller BL, et al. From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTD-17) caused by the P301L tau mutation. Ann Neurol 2000;45:705-715.
11. Colombier C, Geraud G, Delislie MB, Laplanche JI, Pavy le Traon A, et al. Fatal familial insomnia: phenotypic changes determined by polymorphism of the codon 129. Rev Neurol (Paris) 1997; 153: 239-243.
12. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001;28:350-354.
13. Wills AJ, Sawle GV, Guilbert PR, Curtis AR. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry 2002;73:91-92.